You can buy or sell Veru and other stocks, options, ETFs, and crypto commission-free!
Veru Inc. Common Stock, also called Veru, is a urology and oncology biopharmaceutical company, which engages in the development, manufacture and marketing of consumer health care products. Read More It operates through the Commercial; and Research and Development segments. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. The company was founded by William R. Gargiulo Jr. and O.B. Parrish in 1971 and is headquartered in Miami, FL.
52 Week High
52 Week Low
Advertising and Marketing
Research And Development
Veru Inc. Stock Quote (U.S.: Nasdaq)
Veru (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. on Zacks.com...
NASDAQ:VERU - Stock Price, News, & Analysis for Veru
Veru Inc. operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation. The company's urology drug candidates include Tamsulosin delayed release sachet and Tamsulosin XR capsules that are under bioequi...
Expected May 8, Pre-Market